Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

NuVasive acquires Pearsalls' Neodisc

Executive Summary

AMI Holdings' UK subsidiary Pearsalls has licensed NuVasive (medical devices for spinal disorders) the assets related to Neodisc, its nucleus-like replacement device that preserves motion in the cervical area of the spine. NuVasive also received intellectual property associated with an embroidery technology for use in surgical implants.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • Includes Equity
    • Includes Royalty or Profit Split Information
    • Product Purchase
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register